查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1563890

连续血糖监测系统的全球市场

Continuous Glucose Monitoring Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 202 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球连续血糖监测系统市场将达到 103 亿美元

预计 2023 年全球连续血糖监测系统市场规模为 36 亿美元，预计到 2030 年将达到 103 亿美元，2023-2030 年分析期间复合年增长率为 15.9%。感测器组件是本报告分析的细分市场之一，预计复合年增长率为 14.7%，到分析期结束时将达到 54 亿美元。在分析期间，发射器和接收器组件领域预计将以 16.8% 的复合年增长率成长。

美国市场预估价值9.651亿美元，中国预期复合年增长率为22.5%

预计 2023 年美国连续血糖监测系统市场规模将达 9.651 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达28亿美元，2023-2030年分析期间复合年增长率为22.5%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间复合年增长率分别为 12.2% 和 13.0%。在欧洲，德国预计复合年增长率为 12.3%。

全球连续血糖监测系统市场—主要趋势与驱动因素总结

连续血糖监测系统如何彻底改变糖尿病管理？

连续血糖监测 (CGM) 系统透过即时了解血糖浓度，实现更好的血糖控制和更明智的治疗决策，正在彻底改变糖尿病管理。与传统的指尖采血方法不同，CGM 设备透过插入皮下的感测器连续测量血糖浓度，提供可透过智慧型手机或专用读取器存取的资料。这项技术进步极大地提高了追踪血糖值模式和趋势的能力，使患者和医疗保健提供者能够更有效地调整治疗计划。 CGM 系统提供的便利性和准确性对于需要精确胰岛素剂量的 1 型糖尿病患者尤其重要。此外，由于人口老化、久坐的生活方式和肥胖率上升等因素，全球糖尿病盛行率不断上升，这增加了对这些先进监测系统的需求。

哪些技术创新将塑造 CGM 设备的未来？

连续血糖监测系统市场由多项技术创新推动，这些技术创新提高了设备精度、使用者体验和资料分析能力。更小、更舒适、佩戴时间更长、校准次数更少的感测器的开发显着提高了患者的依从性和满意度。新一代 CGM 系统正在与胰岛素帮浦集成，以创建闭合迴路系统或「人工胰臟」设置，可根据即时血糖测量自动进行胰岛素管理。蓝牙技术和智慧型手机应用程式整合的进步使用户能够轻鬆地与看护者和医疗保健提供者共用血糖资料，从而促进更好的糖尿病管理。此外，还采用预测分析和基于人工智慧的演算法来预测潜在的血糖水平趋势，并提供警报以预防高血糖或低血糖。这些技术进步不仅提高了 CGM 系统的有效性，而且使糖尿病管理更加主动和个人化。

监管核准和报销政策如何影响 CGM 市场？

监管部门的核准和优惠的报销政策是推动连续血糖监测系统市场扩张的关键因素。近年来，美国食品药物管理局(FDA) 和欧洲药品管理局 (EMA) 等监管机构已经认识到它们在改善患者治疗效果和降低医疗成本方面的潜力，并加速了新型 CGM 设备的核准。这些监管核准增强了医疗保健提供者和患者对 CGM 系统安全性和有效性的信心。此外，一些国家的保险公司和政府医疗保健计划正在扩大 CGM 设备的覆盖范围，使更多的糖尿病人群能够使用它们。 CGM 系统越来越多地纳入健康保险报销计划，是实现更广泛采用和使用的关键因素，特别是在需要持续监测的老年人和 1 型糖尿病患者中。

推动连续血糖监测系统市场成长的因素有哪些？

连续血糖监测系统市场的成长受到多种因素的推动，例如糖尿病盛行率上升、技术进步以及支持性监管和报销框架。主要驱动因素之一是患者和医疗保健提供者越来越意识到即时血糖监测对于实现更好的血糖控制的好处。与数位健康平台和行动应用程式的整合也推动了 CGM 系统的普及，从而提高了用户参与度和资料驱动的见解。此外，医疗保健行业向基于价值的护理的转变正在推动 CGM 系统的使用，作为减少糖尿病相关併发症和整体医疗保健成本的一种手段。此外，CGM 设备製造商和数位健康公司之间的策略联盟正在推动市场发展，透过资料分析和人工智慧扩展这些设备的功能。这些因素共同促成了全球 CGM 市场的强劲成长前景。

受访企业范例（53家知名企业）

  • Biorasis
  • Carbometrics
  • Dexcom, Inc.
  • GlySens, Inc.
  • Medtronic PLC
  • Metronom Health
  • Nemaura Medical, Inc.
  • PharmaSens
  • Quin Technology
  • Senseonics Holdings, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP15797

Global Continuous Glucose Monitoring Systems Market to Reach US$10.3 Billion by 2030

The global market for Continuous Glucose Monitoring Systems estimated at US$3.6 Billion in the year 2023, is expected to reach US$10.3 Billion by 2030, growing at a CAGR of 15.9% over the analysis period 2023-2030. Sensors Component, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Transmitters & Receivers Component segment is estimated at 16.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$965.1 Million While China is Forecast to Grow at 22.5% CAGR

The Continuous Glucose Monitoring Systems market in the U.S. is estimated at US$965.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 22.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.2% and 13.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.3% CAGR.

Global Continuous Glucose Monitoring Systems Market - Key Trends & Drivers Summarized

How Are Continuous Glucose Monitoring Systems Revolutionizing Diabetes Management?

Continuous Glucose Monitoring (CGM) systems are revolutionizing the management of diabetes by providing real-time insights into glucose levels, allowing for better glycemic control and more informed treatment decisions. Unlike traditional finger-prick methods, CGM devices continuously measure glucose levels through a sensor inserted under the skin, offering data that can be accessed via smartphones or dedicated readers. This technological advancement significantly enhances the ability to track blood glucose patterns and trends, enabling patients and healthcare providers to tailor treatment plans more effectively. The convenience and accuracy provided by CGM systems are especially crucial for patients with Type 1 diabetes, who require precise insulin dosing. Furthermore, the increasing prevalence of diabetes globally, driven by factors such as aging populations, sedentary lifestyles, and rising obesity rates, is amplifying the demand for these advanced monitoring systems.

What Technological Innovations Are Shaping The Future Of CGM Devices?

The Continuous Glucose Monitoring systems market is being propelled by several technological innovations that are enhancing device accuracy, user experience, and data analytics capabilities. The development of smaller, more comfortable sensors that provide longer wear times and require fewer calibrations is significantly improving patient adherence and satisfaction. Next-generation CGM systems are integrating with insulin pumps, creating closed-loop systems or “artificial pancreas” setups that automate insulin delivery based on real-time glucose readings. Advances in Bluetooth technology and smartphone app integrations are allowing users to easily share their glucose data with caregivers and healthcare providers, promoting better diabetes management. Furthermore, predictive analytics and AI-based algorithms are being employed to forecast potential glucose level trends, providing alerts to prevent hyperglycemia or hypoglycemia. These technological advancements are not only enhancing the effectiveness of CGM systems but are also making diabetes management more proactive and personalized.

How Are Regulatory Approvals And Reimbursement Policies Impacting The CGM Market?

Regulatory approvals and favorable reimbursement policies are crucial factors driving the expansion of the Continuous Glucose Monitoring systems market. In recent years, regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have fast-tracked approvals for new CGM devices, recognizing their potential to improve patient outcomes and reduce healthcare costs. These regulatory endorsements have instilled greater confidence among healthcare providers and patients regarding the safety and efficacy of CGM systems. Additionally, insurance companies and government healthcare programs in several countries are expanding their coverage for CGM devices, making them more accessible to a larger segment of the diabetic population. The increasing inclusion of CGM systems in health insurance reimbursement plans is a key factor enabling broader adoption and use, particularly among the elderly and those with Type 1 diabetes who require constant monitoring.

What Factors Are Driving The Growth Of The Continuous Glucose Monitoring Systems Market?

The growth in the Continuous Glucose Monitoring systems market is driven by several factors, including rising diabetes prevalence, technological advancements, and supportive regulatory and reimbursement frameworks. One of the key drivers is the increasing awareness among patients and healthcare providers about the benefits of real-time glucose monitoring for achieving better glycemic control. The growing adoption of CGM systems is also being fueled by their integration with digital health platforms and mobile applications, which offer enhanced user engagement and data-driven insights. Additionally, the shift toward value-based care in the healthcare industry is promoting the use of CGM systems as a means to reduce diabetes-related complications and overall healthcare costs. Further driving the market are strategic partnerships between CGM device manufacturers and digital health companies, which are expanding the capabilities of these devices through data analytics and artificial intelligence. These factors collectively contribute to the robust growth outlook for the CGM market worldwide.

Select Competitors (Total 53 Featured) -

  • Biorasis
  • Carbometrics
  • Dexcom, Inc.
  • GlySens, Inc.
  • Medtronic PLC
  • Metronom Health
  • Nemaura Medical, Inc.
  • PharmaSens
  • Quin Technology
  • Senseonics Holdings, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Continuous Glucose Monitoring Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Diabetes and Need for Continuous Monitoring
    • Technological Advancements in CGM Device Accuracy and Connectivity
    • Rising Adoption of Wearable Health Monitoring Devices
    • Growing Demand for Non-Invasive Glucose Monitoring Solutions
    • Integration of CGM with Digital Health Platforms and Apps
    • Development of AI-Based Predictive Analysis in Diabetes Management
    • Increasing Awareness and Adoption Among Non-Diabetic Users
    • Expanding Availability of CGM Devices in Emerging Markets
    • Government Reimbursement Policies Supporting CGM Adoption
    • Innovations in Miniaturized and Implantable Glucose Sensors
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Continuous Glucose Monitoring Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Sensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transmitters & Receivers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Transmitters & Receivers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Transmitters & Receivers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Integrated Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Integrated Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Integrated Insulin Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinics & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinics & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinics & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for ICUs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • JAPAN
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • CHINA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • EUROPE
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • FRANCE
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • GERMANY
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • INDIA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • AFRICA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030

IV. COMPETITION